$501 Million is the total value of SECTOR GAMMA AS's 29 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 32.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Buy | MERCK & CO INC | $61,050,000 | +72.4% | 812,814 | +78.5% | 12.18% | +94.1% |
| PFE | Sell | PFIZER INC | $28,025,000 | -37.2% | 651,600 | -42.8% | 5.59% | -29.3% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $26,331,000 | -24.7% | 445,010 | -15.0% | 5.25% | -15.2% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $26,150,000 | +40.1% | 602,682 | +38.1% | 5.22% | +57.9% |
| GILD | Sell | GILEAD SCIENCES INC | $25,920,000 | -34.8% | 371,085 | -35.7% | 5.17% | -26.6% |
| CAH | Buy | CARDINAL HEALTH INC | $25,898,000 | +23.0% | 523,606 | +41.9% | 5.17% | +38.5% |
| BIIB | Buy | BIOGEN INC | $23,578,000 | -6.8% | 83,319 | +14.1% | 4.70% | +5.0% |
| MDT | Sell | MEDTRONIC PLC | $23,152,000 | -10.8% | 184,700 | -11.7% | 4.62% | +0.4% |
| INCY | Buy | INCYTE CORP | $20,822,000 | -12.9% | 302,739 | +6.5% | 4.15% | -1.9% |
| BDX | Sell | BECTON DICKINSON & CO | $20,057,000 | -12.9% | 81,593 | -13.8% | 4.00% | -1.9% |
| BAX | Buy | BAXTER INTL INC | $19,096,000 | +23.1% | 237,429 | +23.2% | 3.81% | +38.6% |
| BRKR | Sell | BRUKER CORP | $18,217,000 | -21.8% | 233,252 | -23.9% | 3.63% | -11.9% |
| OGN | Sell | ORGANON & CO | $17,905,000 | +7.1% | 546,062 | -1.1% | 3.57% | +20.7% |
| NUVA | Buy | NUVASIVE INC | $17,861,000 | -10.3% | 298,426 | +1.6% | 3.56% | +1.0% |
| QGEN | Buy | QIAGEN NV | $17,066,000 | +120.4% | 330,220 | +106.3% | 3.40% | +148.1% |
| ANTM | Sell | ANTHEM INC | $16,102,000 | -5.5% | 43,192 | -3.2% | 3.21% | +6.5% |
| CVS | Sell | CVS HEALTH CORP | $14,946,000 | -10.6% | 176,120 | -12.1% | 2.98% | +0.7% |
| XRAY | New | DENTSPLY SIRONA INC | $14,590,000 | – | 251,330 | +100.0% | 2.91% | – |
| CNC | Sell | CENTENE CORP DEL | $13,224,000 | -21.0% | 212,223 | -7.5% | 2.64% | -11.0% |
| ELAN | Buy | ELANCO ANIMAL HEALTH INC | $13,066,000 | -5.0% | 409,731 | +3.3% | 2.61% | +7.0% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $10,655,000 | -11.3% | 37,858 | -13.1% | 2.13% | -0.0% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $8,850,000 | -15.8% | 263,870 | +0.1% | 1.76% | -5.2% |
| BIO | Sell | BIO RAD LABS INCcl a | $8,396,000 | -19.2% | 11,255 | -30.2% | 1.68% | -9.0% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $6,959,000 | +62.7% | 50,295 | +72.2% | 1.39% | +83.1% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $6,435,000 | -13.1% | 1,772,730 | +3.9% | 1.28% | -2.1% |
| PDCO | Buy | PATTERSON COS INC | $5,140,000 | +19.3% | 170,547 | +20.3% | 1.02% | +34.3% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $4,908,000 | -4.8% | 110,767 | +22.1% | 0.98% | +7.2% |
| MRTX | New | MIRATI THERAPEUTICS INC | $4,600,000 | – | 26,000 | +100.0% | 0.92% | – |
| NVAX | Sell | NOVAVAX INC | $2,290,000 | -20.8% | 11,044 | -18.9% | 0.46% | -10.7% |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -14,803 | -100.0% | -0.22% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -4,876 | -100.0% | -0.48% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -234,916 | -100.0% | -0.54% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -30,000 | -100.0% | -0.88% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -68,964 | -100.0% | -1.02% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -117,738 | -100.0% | -1.39% | – |
| PRGO | Exit | PERRIGO CO PLC | $0 | – | -204,732 | -100.0% | -1.66% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -58,017 | -100.0% | -1.74% | – |
| PKI | Exit | PERKINELMER INC | $0 | – | -67,661 | -100.0% | -1.85% | – |
| HSIC | Exit | HENRY SCHEIN INC | $0 | – | -165,721 | -100.0% | -2.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-10-29
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.